The Use of Radium-223 Chloride Therapy in Patients with Castration-Resistant Metastatic Prostate Cancer: A District Hospital Experience

被引：0
|
作者：
Mcaddy, N. C. [1 ]
Lee, H. H. [1 ]
O'Sullivan, P. [1 ]
Crawley, P. [1 ]
Beesley, S. [1 ]
Naji, M. [1 ]
机构：
[1] Maidstone Hlth Author, Maidstone, Kent, England
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP513
引用
收藏
页码：S425 / S425
页数：1
相关论文
共 50 条
  • [1] Use of Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer
    Parker, Chris
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (11) : 723 - 725
  • [2] The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer
    Heinrich, Daniel
    Bektic, Jasmin
    Bergman, Andries M.
    Caffo, Orazio
    Cathomas, Richard
    Chi, Kim N.
    Daugaard, Gedske
    Keizman, Daniel
    Kindblom, Jon
    Kramer, Gero
    Olmos, David
    Omlin, Aurelius
    Sridhar, Srikala S.
    Tucci, Marcello
    van Oort, Inge
    Nilsson, Sten
    CLINICAL GENITOURINARY CANCER, 2018, 16 (01) : E223 - E231
  • [3] Prognostic biomarkers in the use of radium-223 in patients with metastatic castration-resistant prostate cancer
    Vidal, M.
    Cardenas-Perilla, R.
    Delgado, A.
    Moron, S.
    Blair, J. L. Londono
    Vega, I.
    Ochoa, J. J. Correa
    Rojas, J.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (05): : 310 - 317
  • [4] RADIUM-223: TREATING METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    James, D.
    Hillery, R.
    Freeman, L.
    Kumari, A.
    Kearney, N.
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 30 - 31
  • [5] Radium-223 In The Treatment Of Metastatic Castration-Resistant Prostate Cancer
    Vazzana, C.
    Morano, S.
    Di Lascio, A.
    Grana, C.
    Chinol, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S880 - S880
  • [6] Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancer
    Anido-Herranz, Urbano
    Fernandez-Calvo, Ovidio
    Ruiz-Banobre, Juan
    Martinez-Breijo, Sara
    Fernandez-Nunez, Natalia
    Nogareda-Seoane, Zulema
    Garrido-Pumar, Miguel
    Casas-Nebra, Javier
    Muniz-Garcia, Gloria
    Portela-Pereira, Paula
    Gomez-Caamano, Antonio
    Perez-Fentes, Daniel Adolfo
    Santome-Couto, Lucia
    Lazaro, Martin
    Molina-Diaz, Aurea
    Medina-Colmenero, Ana
    Vazquez-Estevez, Sergio
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [7] The Timing of Radium-223 Therapy in Castration-Resistant Prostate Cancer
    Sartor, Oliver
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (09) : 570 - 572
  • [8] Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients
    Fosbol, Marie Obro
    Petersen, Peter Meidahl
    Daugaard, Gedske
    Holm, Soren
    Kjaer, Andreas
    Mortensen, Jann
    ANNALS OF NUCLEAR MEDICINE, 2018, 32 (01) : 16 - 21
  • [9] Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients
    Marie Øbro Fosbøl
    Peter Meidahl Petersen
    Gedske Daugaard
    Søren Holm
    Andreas Kjaer
    Jann Mortensen
    Annals of Nuclear Medicine, 2018, 32 : 16 - 21
  • [10] Clinical Outcome Patterns of Use of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer
    Mackenzie, Colleen
    Deluce, Jasna
    Black, Morgan
    Churchman, Emma
    Winquist, Eric
    Ernst, Scott
    Laidley, David T.
    Parezanovic, Matthew
    Potvin, Kylea
    Fernandes, Ricardo
    CURRENT ONCOLOGY, 2024, 31 (11) : 6475 - 6487
12345